Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

Hemolytic Anemia Clinical Trial

Official title:
Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

Status Completed

Clinical Trial Summary

The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.

Clinical Trial Description

Fifty children and adolescents diagnosed as having alpha thalassemia will be studied, the clinical characteristics and hematology analysis will be summarized. ;

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00971984
Study type	Observational
Source	HaEmek Medical Center, Israel
Contact
Status	Completed
Phase	N/A
Start date	October 2009
Completion date	April 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00001729` - Combination Drug Therapy for Patients With Hepatitis C	Phase 3
Completed	`NCT00110617` - Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients	Phase 2
Active, not recruiting	`NCT05004259` - The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia	Phase 1
Completed	`NCT00842621` - Long Term Effects of Erythrocyte Lysis	N/A
Completed	`NCT02111590` - Immunoglobulin Dosage and Administration Form in CIDP and MMN	N/A
Active, not recruiting	`NCT04610866` - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat	Phase 1/Phase 2